Xoloninvest logo

Xoloninvest

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

Xoloninvest is engaged in investment in early-stage companies, listing, and unlisted mezzanine investment.

Investor Profile

Xoloninvest has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B, Series C rounds (top funding stages).
  • Majority of deals are located in United States, South Korea.
  • Strong thematic focus on Biotechnology, Artificial Intelligence (AI), Machine Learning.

Stage Focus

  • Series B (50%)
  • Series C (50%)

Country Focus

  • United States (50%)
  • South Korea (50%)

Industry Focus

  • Biotechnology
  • Artificial Intelligence (Ai)
  • Machine Learning
  • Medical
  • Neuroscience
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Xoloninvest frequently co-invest with?

Industrial Bank of Korea
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Lifecore Partners
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
NCore Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Kolon Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
DB Financial Investment
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
KB Securities
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
LabGenomics
Asia, Kyonggi-do, South Korea, Bundangdong
Co-Investments: 1
CTK Investments
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
Illumina Ventures
North America, California, United States, Foster City
Co-Investments: 1
Timepolio Asset Management
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1

What are some of recent deals done by Xoloninvest?

NEUROPHET

Gangneung, Kangwon-do, South Korea

NEUROPHET is a medical SW company using advanced neuroscience and AI technologies for better brain treatment.

Artificial Intelligence (AI)Machine LearningMedicalNeuroscienceSoftware
Series CNov 7, 2023
Amount Raised: $15,325,964
Rebus Biosystems

Santa Clara, California, United States

Rebus Biosystems is a life science technology company creating revolutionary tools to enable spatial omics research without compromise.

Biotechnology
Series BNov 19, 2020
Amount Raised: $20,000,000